Yahoo
NSE - Delayed Quote INR

Max Healthcare Institute Limited (MAXHEALTH.NS)

860.00 +8.85 (+1.04%)
At close: October 30 at 3:28:17 PM GMT+5:30
MAXHEALTH.NS Q2 2027 earnings call
November 3, 2026 at 12:00 PM GMT+5:30
Chart Range Bar
Loading chart for MAXHEALTH.NS
  • Previous Close 851.15
  • Open 851.00
  • Bid 860.00 x --
  • Ask --
  • Day's Range 849.40 - 882.95
  • 52 Week Range 797.00 - 1,185.40
  • Volume 6,876,824
  • Avg. Volume 2,708,858
  • Market Cap (intraday) 837.061B
  • Beta (5Y Monthly) 0.10
  • PE Ratio (TTM) 60.86
  • EPS (TTM) 14.13
  • Earnings Date (est.) Nov 20, 2026
  • Forward Dividend & Yield 2.00 (0.23%)
  • Ex-Dividend Date Jul 3, 2026
  • 1y Target Est 1,150.59

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine, organ transplants, and plastic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and Max Lab, which provides diagnostic testing services to patients. In addition, it offers organ and tissue donation, preventive health checks, ambulance and immigration, air ambulance, and insurance and TPA services. The company provides healthcare services through a network of primary care clinics, multi-specialty hospitals/medical centres, and super-specialty hospital facilities. Max Healthcare Institute Limited was incorporated in 2001 and is based in Gurugram, India.

www.maxhealthcare.in

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

MAXHEALTH.NS
17.56%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

MAXHEALTH.NS
26.90%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

MAXHEALTH.NS
49.96%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

MAXHEALTH.NS
161.19%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 25.69B
Earnings 4.15B
Profit Margin 16.15%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
5B
10B
15B
20B
25B
14.0%
14.5%
15.0%
15.5%
16.0%

Analyst Insights

View More

Analyst Price Targets

825.00
1,150.59 Average
860.00 Current
1,320.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.09%

  • Return on Assets (ttm)

    6.98%

  • Return on Equity (ttm)

    12.79%

  • Revenue (ttm)

    91.46B

  • Net Income Avi to Common (ttm)

    13.81B

  • Diluted EPS (ttm)

    14.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.71B

  • Total Debt/Equity (mrq)

    32.90%

  • Levered Free Cash Flow (ttm)

    2B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: